Press Releases May 15, 2026 04:01 PM

Materialise to Hold Annual Shareholders’ Meeting on June 16, 2026

Materialise NV announces date for its 2026 Annual General Shareholders’ Meeting

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
MTLS

Materialise NV, a leader in 3D-printed medical devices and additive manufacturing software, will hold its Annual General Shareholders' Meeting on June 16, 2026. The company provides advanced 3D printing software and services to multiple industries globally and shares information on its website for shareholders.

Materialise to Hold Annual Shareholders’ Meeting on June 16, 2026
MTLS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Materialise NV has scheduled its 2026 Annual General Shareholders' Meeting on June 16, 2026.
  • The company operates globally with a strong presence in 3D printing software and medical device manufacturing.
  • Materialise supports various sectors including healthcare, automotive, aerospace, and consumer goods through its 3D printing solutions.

LEUVEN, Belgium, May 15, 2026 (GLOBE NEWSWIRE) -- Materialise NV (Euronext & NASDAQ &: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced that it will host its Annual General Shareholders’ Meeting (AGM) on Tuesday, June 16, 2026, at 10:00 am CET. 

The convening notices and other documents pertaining to the Annual General Shareholders’ Meeting, including the annual report, are available on Materialise's website at https://investors.materialise.com/shareholder-information/general-meetings.

About Materialise

Materialise NV incorporates more than three decades of 3D printing experience into a range of software solutions and 3D printing services that empower sustainable 3D printing applications. Our open, secure, and innovative end-to-end solutions enable flexible industrial manufacturing and mass personalization in various industries — including healthcare, automotive, aerospace, eyewear, art and design, wearables, and consumer goods. Headquartered in Belgium and with branches worldwide, Materialise NV combines the largest group of software developers in the industry with one of the world's largest and most complete 3D printing facilities. For additional information, please visit: www.materialise.com.

[1] The enclosed information constitutes regulated information as defined in the Belgian Royal Decree of 14 November 2007 regarding the duties of issuers of financial instruments which have been admitted for trading on a regulated market.


Risks

  • The notice does not mention any new strategic developments, which may limit immediate investor enthusiasm.
  • Industry-wide risks related to 3D printing technology adoption and regulatory approvals, particularly in healthcare, may impact growth.
  • Materialise being a multinational company faces risks related to global economic and trade conditions.

More from Press Releases

Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism Jun 13, 2026 Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026